Sanket Agrawal is a dynamic senior biopharmaceutical leader with a track record of delivering value and mission-critical outcomes in his field. He has experience in advancing novel therapies, leading cross-functional teams, and building sustained winning cultures. Sanket has a diverse background that integrates biopharma drug development and commercialization, organization scaling and transformation, and AIML/Big-Data/Digital. He graduated with a B. Eng. in Delhi College of Engineering, an M. Eng. at the University of Toronto, an MPH at the University of Liverpool, and an MBA at the University of California, Los Angeles - The Anderson School of Management.

Sanket has held various executive-level positions throughout his career at Amgen, Relsys International, Deloitte Consulting, and Accenture. He is currently the Global Product General Manager of Oncology at Amgen, leading the KRAS Franchise-Sotorasib. Notably, he has also served as Head of Global Commercial, Oncology/Hematology Pipeline, Global Commercial Lead of Oncology, Executive Director of Strategy and Operations (R&D/Regulatory), Chief Business Officer at Relsys International (Oracle Health Sciences), and VP/GM at Relsys International (Oracle Health Sciences). He also co-founded and was principal of SAVtech Solutions.

Sanket is a lifelong learner, entrepreneur, and compassionate, empowering leader, with a proven ability to succeed across boundaries and roles. He has repeatedly built "new oncology" franchises, immuno and precision - leveraging diagnostics, novel trials, fast-to-market, and business development while optimizing science, speed, and the market. He has also delivered robust commercial results, including portfolio strategy, new product planning, brand positioning, value, innovative go-to-market models, financial, and operational performance.